About Our Factory & Business Background Address 68 Ganjiang Road, Shijiazhuang Economic and Technological Development Zone, Shijiazhuang, Hebei, China Terms of Payment LC, T/T, D/P, PayPal, Western Union, Small-amount payment International Commercial Terms(Incoterms) FOB, CIF, CFR Average Lead Time Peak Season Lead Time: within 15 workdays Off Season Lead Time: within 15 workdays Nearest Port Tianjin Port Our Production Capability & Technical Expertise Main Products Veterinary Medicine, Ivermectin, Eprinomectin, Oxytetracycline Hydrochloride, Tiamulin Hydrogen Fumarate, Ivermectin Injection, Oxytetracycline Injection, Albendazole Bolus, Abamectin, Tilmicosin Production Machines Tiamulin Fumarate Production Equipment, Ivermectin Production Equipment ODM Service Available Yes OEM Service Available Yes R&D Engineers 15 people Own Brand Yes Our Industry Experience & Global Business Record Export Year 2003-02-01 Main Markets South America, Southeast Asia/ Mideast, Africa Number of Foreign Trading Staff 20 Overseas Agent/Branch No Send your message to this supplier People who viewed this also viewed US$150.00-160.00 / kg Find Similar Products By Category Supplier Homepage Products Veterinary Medicine Complex Vitamin B Injection Vitamin B6, Vitamin B12 Injection OEM&ODM Service Veterinary Drug Related Categories Hot Searches Water For Injection Factories Pharmaceutical Medicine Factories China Vitamin Factories Vitamin H Factories Vitamin Medicine Vitamin C Injection Vitamin Solution Vitamin For Injection Vitamin K Injection Veterinary Medicine Bulkbuy
Remember Bri
The stress kinases in turn phosphorylate eukaryotic initiation factor 2 (eIF2) and the collective effects of eIF2 activation is termed the ISR 14
Modulating CD47SIRP signaling may regulate RBC clearance in autoimmune hemolytic anemia, whereas attenuating ICAM-4 and CD36 activity could mitigate vascular occlusion and inflammatory adhesion in sickle cell disease (48)
Oral small molecules beyond orforglipron, additional dual agonists, and standalone amylin agents are all in Phase 2, reflecting a field that is no longer betting on one approach
